General Notices

• AHRQ Notice of Extension of PA-18-793
  (NOT-HS-21-005)
  Agency for Healthcare Research and Quality
  

Notice of Changes to Funding Opportunities

• Notice of Changed Application Forms for RFA-CA-20-049 "New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)"
  (NOT-CA-21-024)
  National Cancer Institute
  

• Notice of Change of Key Dates for RFA-HD-22-003 "Contraception Development Research Center Program (P50 Clinical Trial Optional)"
  (NOT-HD-20-044)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Clarification to Career Stages Supported for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
  (NOT-NS-21-019)
  National Institute of Neurological Disorders and Stroke
  National Institute of Mental Health
  

• Notice of Change to Award Budget for PHS 2020-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
  (NOT-OD-21-039)
  National Institutes of Health
  

• Notice of NCATS Withdrawal from Participation in PAR-20-243, "Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)"
  (NOT-TR-21-012)
  National Center for Advancing Translational Sciences
  

• Notice of NCATS Withdrawal from Participation in PAR-20-165, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)"
  (NOT-TR-21-013)
  National Center for Advancing Translational Sciences
  

• Notice of NCATS Withdrawal from Participation in PAR-20-168, "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)"
  (NOT-TR-21-014)
  National Center for Advancing Translational Sciences
  

Requests for Proposal

• Pre Solicitation Notice: Clinical Pharmacology Quality Assurance (CPQA) Program, RFP: 75N93021R00003
  (NOT-AI-21-010)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease
  (NOT-AG-20-053)
  National Institute on Aging
  

• Notice of Special Interest (NOSI): Discovery of the Genetic Basis of Conditions Associated with Down Syndrome for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (X01)
  (NOT-HD-20-039)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
  (NOT-MD-21-008)
  National Institute on Minority Health and Health Disparities
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
  (NOT-MH-21-075)
  National Institute of Mental Health
  National Eye Institute
  National Institute on Aging
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
  (NOT-TR-21-011)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32)
  (PAR-21-093)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Standard dates apply. The first application due date for this FOA is April 8, 2021.
  
  

• NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
  (PAR-21-107)
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): February 26, 2021; June 24, 2021; October 28, 2021; February 24, 2022; June 23, 2022; October 27, 2022; February 23, 2023; June 29, 2023; October 26,2023
  
  

• Limited Competition: National Institute on Aging (NIA) Late Onset of Alzheimers Disease (LOAD) Family-Based Study (FBS) (U24 Clinical Trial Not Allowed)
  (RFA-AG-22-001)
  National Institute on Aging
  Application Receipt Date(s): February 17, 2021. No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Engaging the dental workforce to end the HIV epidemic in the U.S. (UG3/UH3 Clinical Trial Required)
  (RFA-DE-21-002)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 10, 2021
  
  

• Renewal - Strengthen and Promote the Role of Local Health Departments in Retail Food Safety Regulation (U50 Clinical Trial Not Allowed
  (RFA-FD-21-011)
  Food and Drug Administration
  Application Receipt Date(s): February 12, 2021 by 11:59 PM Eastern Time.